Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 09, 2022 | May 11, 2022 |
| TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943 | Director | May 19, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 09, 2022 · Filed May 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,448 |
Reported balance
After 2022-05-09 transaction · row 1
1 source rowRow 1 · 2022-05-09 · Grant · Acquired 12,103 · Balance 15,448 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
TREACE MEDICAL CONCEPTS, INC.
Report date May 19, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,243 |
Reported balance
After 2026-05-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 30,000 · Balance 100,243 F1: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2: Includes 30,000 restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.
F2: Includes 30,000 restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 20, 2026 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-231463 · ownership.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,243 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2 · balance_after: Includes 30,000 restricted stock units. Read SEC document |
| May 20, 2025 Filed May 21, 2025 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 23,917 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075894 · ownership.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,243 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2 · balance_after: Includes 23,917 restricted stock units. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 33,260 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0000950170-24-063612 · ownership.xml · derivative · entry 2 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,260 Underlying: Common Stock · 33,260 shares Expires 2034-05-21 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 15,091 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063612 · ownership.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,326 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2 · balance_after: Includes 15,486 restricted stock units. Read SEC document |
| May 10, 2024 Filed May 13, 2024 23:49 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | PurchaseCommon Stock | 25,000 | $4.50 | $112,567.50 |
DisclosureSEC source: 0000950170-24-058990 · ownership.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,235 F1 · balance_after: Includes 3940 restricted stock units Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 6,305 | $0.00 Strike: $26.34 | $0.00 |
DisclosureSEC source: 0001209191-23-032349 · doc4.xml · derivative · entry 2 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,305 Underlying: Common Stock · 6,305 shares Expires 2033-05-23 F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032349 · doc4.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,235 F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. F2 · balance_after: Includes 3,940 RSUs. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:35 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 16,625 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001567619-22-011342 · doc1.xml · derivative · entry 4 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2032-05-17 F4 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:35 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 8,600 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001567619-22-011342 · doc1.xml · derivative · entry 3 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,600 Underlying: Common Stock · 8,600 shares Expires 2032-05-17 F3 · derivative.exercise_date: The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:35 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 2,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011342 · doc1.xml · nonDerivative · entry 2 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,482 F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:35 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011342 · doc1.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:28 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011959 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,448 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 01:42 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | PurchaseStock Option (Right to Buy) · Derivative | 17,750 | $0.00 Strike: $26.52 | $0.00 |
DisclosureSEC source: 0001567619-21-017868 · doc1.xml · derivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,750 Underlying: Common Stock · 17,750 shares Expires 2031-10-01 F1 · derivative.exercise_date: The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2021 such that the stock option will be fully vested and exercisable on October 1, 2024, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:06 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012781 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 01:36 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004640 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.